The latest IMARC Group report entitled “Artificial Heart-Lung Machines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecasts 2022-2027‘, provides a comprehensive analysis of the industry that includes insights Industry size of the artificial heart-lung machine. The report also includes competitive and regional analysis along with current advances in the global market. The global artificial heart-lung machine market size reached US$270.6 million in 2021 The market is projected to reach $339.5 million by 2027, at a growth rate (CAGR) of 3.77% over 2022-2027.

An artificial heart-lung machine, also known as an oxygenator pump or cardiopulmonary bypass (CPB), is used in heart and lung transplants, coronary artery bypass grafts, and other heart surgeries. It temporarily performs functions that allow the surgeon to operate on the move and in a bloodless surgical field. Artificial heart-lung machines consist of a chamber that holds blood, which then circulates and oxygenates all parts of the body. These pumps have helped make significant advances in the management of severe respiratory failure and cardiac surgery. As a result, the artificial heart-lung machine finds widespread applications in hospitals, clinics, outpatient surgical centers, etc.

Get a free sample copy of this report: https://www.imarcgroup.com/artificial-heart-lung-machine-market/requestsample

As the novel coronavirus (COVID-19) crisis sweeps the world, we continuously monitor the changes in the markets and consumer purchasing behavior worldwide and our estimates on the latest market trends and forecasts are made after considering the impact of this pandemic.

Global Artificial Heart-Lung Machine Market Trends:

The increasing prevalence of cardiovascular diseases and organ failure, caused by the diverse environmental and lifestyle changes, is driving above all the artificial…